Kelly Davison

2.1k total citations
13 papers, 830 citations indexed

About

Kelly Davison is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Kelly Davison has authored 13 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Kelly Davison's work include Retinoids in leukemia and cellular processes (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). Kelly Davison is often cited by papers focused on Retinoids in leukemia and cellular processes (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). Kelly Davison collaborates with scholars based in Canada, United States and France. Kelly Davison's co-authors include Wilson H. Miller, Koren K. Mann, Samuel Waxman, Sylvie Mader, Clara Nervi, William W. Lamph, Pier Giuseppe Pelicci, Angelika Rosenauer, Carlo Gambacorti‐Passerini and C Peschle and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Kelly Davison

12 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Davison Canada 9 639 275 143 133 119 13 830
Guan-Lin Sun China 6 1.2k 1.9× 591 2.1× 106 0.7× 298 2.2× 155 1.3× 7 1.4k
Elena Puccetti Germany 17 902 1.4× 524 1.9× 137 1.0× 55 0.4× 95 0.8× 28 1.1k
Jennifer M. Grad United States 7 432 0.7× 116 0.4× 126 0.9× 39 0.3× 118 1.0× 7 661
W-L Zhao China 10 576 0.9× 263 1.0× 134 0.9× 27 0.2× 38 0.3× 12 845
Zhu Chen China 10 388 0.6× 137 0.5× 43 0.3× 51 0.4× 52 0.4× 19 529
Suwei Dong China 16 735 1.2× 252 0.9× 177 1.2× 49 0.4× 152 1.3× 42 1.1k
John D. Broome United States 10 309 0.5× 73 0.3× 185 1.3× 32 0.2× 50 0.4× 11 631
Z Chen China 15 1.7k 2.7× 927 3.4× 124 0.9× 376 2.8× 232 1.9× 21 2.0k
Young Yiul Lee South Korea 14 335 0.5× 63 0.2× 185 1.3× 10 0.1× 69 0.6× 27 722

Countries citing papers authored by Kelly Davison

Since Specialization
Citations

This map shows the geographic impact of Kelly Davison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Davison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Davison more than expected).

Fields of papers citing papers by Kelly Davison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Davison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Davison. The network helps show where Kelly Davison may publish in the future.

Co-authorship network of co-authors of Kelly Davison

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Davison. A scholar is included among the top collaborators of Kelly Davison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Davison. Kelly Davison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Jafri, Mariam, Jan‐Willem Henning, Kelly Davison, et al.. (2023). Accrual of adolescents and young adults (AYA) into cancer clinical trials in Canada.. Journal of Clinical Oncology. 41(16_suppl). e13598–e13598.
2.
Malagón, Talía, Farzin Khosrow‐Khavar, Doneal Thomas, et al.. (2023). End of life in haematology: quality of life predictors – retrospective cohort study. BMJ Supportive & Palliative Care. 14(e3). e2708–e2718. 4 indexed citations
3.
Herrera, Alex F., Michael LeBlanc, Sharon M. Castellino, et al.. (2023). SWOG S1826, a randomized study of nivolumab(N)-AVD versus brentuximab vedotin(BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL).. Journal of Clinical Oncology. 41(17_suppl). LBA4–LBA4. 66 indexed citations
4.
Rutherford, Sarah C., Hongli Li, Alex F. Herrera, et al.. (2023). Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826. Blood. 142(Supplement 1). 181–181. 16 indexed citations
5.
Castellino, Sharon M., Michael LeBlanc, Alex F. Herrera, et al.. (2020). An intergroup collaboration for advanced stage classical Hodgkin lymphoma (cHL) in adolescents and young adults (AYA): SWOG S1826.. Journal of Clinical Oncology. 38(15_suppl). TPS8067–TPS8067. 3 indexed citations
6.
7.
8.
Mann, Koren K., Kelly Davison, April Colosimo, et al.. (2005). Antimony trioxide-induced apoptosis is dependent on SEK1/JNK signaling. Toxicology Letters. 160(2). 158–170. 50 indexed citations
9.
Davison, Kelly, Koren K. Mann, Samuel Waxman, & Wilson H. Miller. (2004). JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells. Blood. 103(9). 3496–3502. 125 indexed citations
10.
Davison, Kelly, et al.. (2003). Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines. Leukemia. 17(5). 931–940. 138 indexed citations
11.
Davison, Kelly, Koren K. Mann, & Wilson H. Miller. (2002). Arsenic trioxide: Mechanisms of action. Seminars in Hematology. 39(2). 3–7. 82 indexed citations
12.
Shao, Wenlin, Mirco Fanelli, Fabiana Fosca Ferrara, et al.. (1998). Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia Cells. JNCI Journal of the National Cancer Institute. 90(2). 124–133. 303 indexed citations
13.
Rosenauer, Andreas, Clara Nervi, Kelly Davison, et al.. (1998). Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.. PubMed. 58(22). 5110–6. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guan-Lin Sun Breakdown of academic impact, for papers by Elena Puccetti Breakdown of academic impact, for papers by Jennifer M. Grad Breakdown of academic impact, for papers by W-L Zhao Breakdown of academic impact, for papers by Zhu Chen Breakdown of academic impact, for papers by Suwei Dong Breakdown of academic impact, for papers by John D. Broome Breakdown of academic impact, for papers by Z Chen Breakdown of academic impact, for papers by Young Yiul Lee
Rankless by CCL
2026